MBIO logo

Mustang Bio (MBIO) Company Overview

Profile

Full Name:

Mustang Bio, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

August 22, 2017

Indexes:

Not included

Description:

Mustang Bio is a biotechnology company focused on developing innovative therapies for cancer and rare diseases. They use advanced gene and cell therapy techniques to create treatments that aim to improve patient outcomes and quality of life. Their goal is to bring new hope to patients with serious health conditions.

Events Calendar

Earnings

Next earnings date:

Mar 11, 2025

Recent quarterly earnings:

Nov 8, 2024

Recent annual earnings:

Mar 11, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jan 16, 2025

Analyst ratings

Recent major analysts updates

May 16, 24 HC Wainwright & Co.
Buy
May 13, 24 HC Wainwright & Co.
Buy
Aug 24, 23 Cantor Fitzgerald
Overweight
Aug 16, 23 HC Wainwright & Co.
Buy
Aug 15, 23 HC Wainwright & Co.
Buy
Aug 15, 23 BTIG
Buy
Jun 16, 23 HC Wainwright & Co.
Buy
Jun 16, 23 BTIG
Buy
May 15, 23 HC Wainwright & Co.
Buy
Mar 30, 23 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Mustang Bio?
  • Does Mustang Bio pay dividends?
  • What sector is Mustang Bio in?
  • What industry is Mustang Bio in?
  • What country is Mustang Bio based in?
  • When did Mustang Bio go public?
  • Is Mustang Bio in the S&P 500?
  • Is Mustang Bio in the NASDAQ 100?
  • Is Mustang Bio in the Dow Jones?
  • When was Mustang Bio's last earnings report?
  • When does Mustang Bio report earnings?
  • Should I buy Mustang Bio stock now?

What is the ticker symbol for Mustang Bio?

The ticker symbol for Mustang Bio is NASDAQ:MBIO

Does Mustang Bio pay dividends?

No, Mustang Bio does not pay dividends

What sector is Mustang Bio in?

Mustang Bio is in the Healthcare sector

What industry is Mustang Bio in?

Mustang Bio is in the Biotechnology industry

What country is Mustang Bio based in?

Mustang Bio is headquartered in United States

When did Mustang Bio go public?

Mustang Bio's initial public offering (IPO) was on August 22, 2017

Is Mustang Bio in the S&P 500?

No, Mustang Bio is not included in the S&P 500 index

Is Mustang Bio in the NASDAQ 100?

No, Mustang Bio is not included in the NASDAQ 100 index

Is Mustang Bio in the Dow Jones?

No, Mustang Bio is not included in the Dow Jones index

When was Mustang Bio's last earnings report?

Mustang Bio's most recent earnings report was on Nov 8, 2024

When does Mustang Bio report earnings?

The next expected earnings date for Mustang Bio is Mar 11, 2025

Should I buy Mustang Bio stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions